REFERENCES
1. Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8‑13.
2. Stone C, Brown NJ. Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema. Immunol Allergy Clin North Am. 2017;37(3):483‑95.
3. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842‑56.
4. Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 15 oct 1999;44(1‑2):21‑5.
5. Campo P, Fernandez TD, Canto G, Mayorga C. Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol. août 2013;13(4):337‑44.
6. Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature. J Clin Hypertens Greenwich Conn. déc 2017;19(12):1377‑82.
7. Mahmoudpour SH, Baranova EV, Souverein PC, Asselbergs FW, de Boer A, Maitland-van der Zee AH, et al. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. 2016;82(6):1647‑59.
8. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. avr 2008;100(4):327‑32.
9. Nosbaum A, Bouillet L, Floccard B, Javaud N, Launay D, Boccon-Gibod I, et al. Prise en charge des angiœdèmes induits par les inhibiteurs de l’enzyme de conversion de l’angiotensine : recommandations du Centre de référence national des angiœdèmes. Rev Médecine Interne. 1 avr 2013;34(4):209‑13.
10. Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE Inhibitor-Induced Angioedema: a Review. Curr Hypertens Rep. 08 2018;20(7):55.
11. Pfaue A, Schuler PJ, Mayer B, Hoffmann TK, Greve J, Hahn J. Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients. J Community Hosp Intern Med Perspect. 2019;9(6):453‑9.
12. Sánchez-Borges M, González-Aveledo LA. Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res. juill 2010;2(3):195‑8.
13. Roberts JR, Lee JJ, Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol. 1 mars 2012;109(5):774‑5.
14. Weisman DS, Arnouk N, Asghar MB, Qureshi MR, Kumar A, Desale S, et al. ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients. J Community Hosp Intern Med Perspect. 2020;10(1):16‑8.
15. Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. janv 2007;98(1):57‑63.
16. Javaud N, Achamlal J, Reuter P-G, Lapostolle F, Lekouara A, Youssef M, et al. Angioedema Related to Angiotensin-Converting Enzyme Inhibitors: Attack Severity, Treatment, and Hospital Admission in a Prospective Multicenter Study. Medicine (Baltimore). nov 2015;94(45):e1939.
17. Sinert R, Levy P, Bernstein JA, Body R, Sivilotti MLA, Moellman J, et al. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema. J Allergy Clin Immunol Pract. oct 2017;5(5):1402-1409.e3.
18. Straka BT, Ramirez CE, Byrd JB, Stone E, Woodard-Grice A, Nian H, et al. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. juill 2017;140(1):242-248.e2.
19. Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med. sept 2010;56(3):278‑82.
20. Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 29 janv 2015;372(5):418‑25.
21. Bova M, Guilarte M, Sala-Cunill A, Borrelli P, Rizzelli GML, Zanichelli A. Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med. avr 2015;10(3):345‑50.
22. Grant NN, Deeb ZE, Chia SH. Clinical experience with angiotensin-converting enzyme inhibitor–induced angioedema. Otolaryngol Neck Surg. 1 déc 2007;137(6):931‑5.
23. Chiu A, Newkirk K, Davidson B, Burningham A, Krowiak E, Deeb Z. Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Multicenter Review and an Algorithm for Airway Management. Ann Otol Rhinol Laryngol. 1 oct 2001;110:834‑40.
24. Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015;2.
25. Maurer M, Magerl M. Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema. Clin Rev Allergy Immunol [Internet]. 3 févr 2021 [cité 15 févr 2021]; Disponible sur: https://doi.org/10.1007/s12016-021-08841-w